Intellicell Biosciences Inc (OTC Pink - Current Information:SVFC)

0.0001
Delayed Data
As of Mar 05
 0.00 / 0.00%
Today’s Change
0.00
Today|||52-Week Range
0.01
-33.33%
Year-to-Date
SECTOR
Technology Services
INDUSTRY
Information Technology Services
MARKET CAP
$789.4K

Company Description

Intellicell Biosciences, Inc. operates as a regenerative medicine company focused on the expanding regenerative medical markets using a proprietary, patent pending process to separate adult autologous vascular cells from blood vessels in adult adipose tissue. The company has developed its own patent pending protocol to separate adult autologous vascular cells from adipose tissue without the use of enzymes. It will also be seeking to develop technology licensing agreements with technology developers, universities, and international business entities. Intellicell Biosciences was founded on June 3, 2011 and is headquartered in New York, NY.

Contact Information

Intellicell Biosciences, Inc.
460 Park Avenue
New York New York 10022
P:(646) 576-8700
Investor Relations:

Employees

Shareholders

Individual stakeholders0.06%
Mutual fund holders--
Other institutional--

Top Executives

Steven A. VictorPresident, CEO, Secretary & Treasurer
Leonard L. MazurChief Operating Officer & Director
John HuberChief Financial Officer
Anna RhodesExecutive Vice President-Operations
Vincent S. DuganDirector-National Sales

To view my watchlist

Not a member yet?

Sign up now for a free account